FORM 1 - Individual Substantial Shareholder Notice
 
Form Serial Number: IS20171004E00072
(Amendment to IS20170921E00154)
1. Date of relevant event: 21/09/2017
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 08158
4. Name of listed corporation: China Regenerative Medicine International Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 17,585,790,000
7. Name of substantial shareholder (English) as printed on HKID Card/Passport:
(Surname) Dai
(Other names) Yumin
10. Name of substantial shareholder (Chinese): 戴昱敏 
11. Chinese Character Code as printed on HKID Card: 207125092404
 
14. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position 
1101The percentage level of your interest in the shares has increased because:
you purchased the shares
 
 
2101Beneficial owner
 
9,955,000  HKD  0.1890  0.1870   
 
Short position 
 
 
 
           
15. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position4,978,865,31928.31
Short position4,201,765,31923.89
 
16. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position4,988,820,31928.37
Short position4,201,765,31923.89
 
17. Capacity in which interests disclosed in Box 16 are held:
Capacity codeNumber of shares
2201Interest of corporation controlled by you
Long position3,708,100,319
Short position3,708,100,319
2101Beneficial owner
Long position1,273,005,000
Short position493,665,000
2202Interest of your spouse
Long position7,715,000
Short position0
 
18. Further information in respect of derivative interests:
Derivatives codeNumber of shares
4105Unlisted derivatives - Physically settled
Long position17,500,000
 
19. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseDeng Shufen
Long position7,715,000
Short position0
 
20. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling shareholder% controlDirect interest (Y/N)Number of shares
Nat-Ace Wood Industry Ltd.Akara Building, 24 De Castro Street, Wickhams Cays 1, Road Town, Tortola, British Virgin IslandsDai Yumin100.00N
Long position3,708,100,319
Short position3,708,100,319
All Favour Holdings LimitedP.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin IslandsNat-Ace Wood Industry Ltd.40.00Y
Long position3,708,100,319
Short position3,708,100,319
All Favour Holdings LimitedP.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin IslandsDai Yumin40.00Y
Long position3,708,100,319
Short position3,708,100,319
All Favour Holdings LimitedP.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin IslandsHonour Top Holdings Limited20.00Y
Long position3,708,100,319
Short position3,708,100,319
Honour Top Holdings LimitedWoodbourne Hall, Road Town, Tortola, British Virgin IslandsDai Yumin100.00N
Long position3,708,100,319
Short position3,708,100,319
 
21. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
22. Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
  
 
23. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
 
24. Supplementary information: In respect of Box 20, Dai Yumin acquired 40% interest in All Favour Holdings Limited ("AFH"). Together with the 60% interest in AFH ultimately held by Dai Yumin prior to such acquisition, Dai Yumin holds 100% interest in AFH, which holds 3,708,100,319 shares in China Regenerative Medicine International Limited ("CRMI"), representing approximately 21.09% of the issued share capital of CRMI as at the date of the relevant event. Box 20 of previously submitted form (IS20170921E00154) revised.
25. Log/Serial Number of the previous form: IS20170921E00154
26. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 1: 04/10/2017
(dd/mm/yyyy)